HI
AMED

HBK Investments’s Amedisys AMED Stock Holding History

HBK Investments’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-18,739
Closed -$2.31M – 618
2019
Q1 		$2.31M Sell
18,739
-7,991
-30% -$1M 0.02% 472
2018
Q4 		$3.13M Buy
26,730
+12,749
+91% +$1.5M 0.03% 383
2018
Q3 		$1.75M Buy
+13,981
New +$1.54M 0.01% 566
2018
Q2 		– Sell
-6,885
Closed -$415K – 1004
2018
Q1 		$415K Sell
6,885
-41,415
-86% -$2.36M ﹤0.01% 801
2017
Q4 		$2.55M Buy
48,300
+44,395
+1,137% +$2.34M 0.02% 395
2017
Q3 		$219K Buy
+3,905
New +$207K ﹤0.01% 950
2017
Q2 		– Sell
-15,034
Closed -$768K – 906
2017
Q1 		$768K Sell
15,034
-27,966
-65% -$1.33M 0.01% 455
2016
Q4 		$1.83M Buy
43,000
+1,600
+4% +$68K 0.02% 352
2016
Q3 		$1.96M Buy
41,400
+17,200
+71% +$858K 0.02% 373
2016
Q2 		$1.22M Sell
24,200
-4,635
-16% -$234K 0.01% 521
2016
Q1 		$1.39M Sell
28,835
-21,069
-42% -$813K 0.01% 516
2015
Q4 		$1.96M Buy
49,904
+40,459
+428% +$1.62M 0.02% 401
2015
Q3 		$359K Sell
9,445
-955
-9% -$40.3K ﹤0.01% 824
2015
Q2 		$413K Sell
10,400
-8,600
-45% -$268K ﹤0.01% 763
2015
Q1 		$509K Sell
19,000
-12,900
-40% -$364K ﹤0.01% 730
2014
Q4 		$936K Buy
+31,900
New +$788K 0.01% 567

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

HBK Investments's AMED Position: Q2 2019 in Review

HBK Investments sold out of Amedisys (AMED) in Q2 2019, closing a stake of 18,739 shares — an estimated $2.31M sold.

HBK Investments first reported a position in AMED in Q4 2014 and held it in 16 quarters. The position peaked at $3.13M in Q4 2018. 285 funds tracked by Wall St. Rank hold AMED as of Q2 2019.

  • HBK Investments reported no remaining Amedisys position as of Q2 2019 after selling out during the quarter.
  • HBK Investments sold 18,739 Amedisys shares in Q2 2019, an estimated $2.31M.
  • HBK Investments first reported a position in Amedisys in Q4 2014 and held it in 16 quarters.
  • HBK Investments's Amedisys position peaked at $3.13M in Q4 2018.
  • 285 funds tracked by Wall St. Rank held Amedisys as of Q2 2019.

Based on HBK Investments's 13F filing for Q2 2019, filed 14 Aug 2019.